US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 11.690
  • -0.010-0.09%
Close Aug 14 16:00 ET
386.48MMarket Cap-5002P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-52.76%-20.15M
19.09%-14.87M
-9.05%-59.5M
15.91%-13.98M
-18.32%-13.95M
-13.19M
-18.37M
-23.49%-54.56M
-16.63M
-11.79M
Net income from continuing operations
-58.00%-21.24M
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
---13.44M
---18.66M
-17.10%-59.28M
---14.58M
---17.06M
Depreciation and amortization
11.21%496K
6.49%476K
60.96%1.84M
10.11%490K
34.50%460K
--446K
--447K
8,707.69%1.15M
--445K
--342K
Other non cash items
----
----
--530K
--258K
----
----
----
----
----
----
Change In working capital
-93.65%-2.26M
814.44%4.01M
-17.25%1.48M
55.36%-1.35M
1.36%4.55M
---1.17M
---561K
-70.35%1.79M
---3.02M
--4.49M
-Change in prepaid assets
557.98%861K
-138.36%-201K
152.46%990K
184.30%698K
-109.89%-44K
---188K
--524K
-247.51%-1.89M
---828K
--445K
-Change in payables and accrued expense
-297.59%-2.81M
707.25%4.52M
-52.56%1.91M
13.18%-1.73M
20.31%5.09M
---706K
---745K
-39.67%4.03M
---1.99M
--4.23M
-Change in other current liabilities
-14.39%-310K
7.35%-315K
-366.78%-1.42M
-59.80%-318K
-170.72%-490K
---271K
---340K
---304K
---199K
---181K
-Change in other working capital
----
----
----
----
----
----
----
50.54%-46K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-52.76%-20.15M
19.09%-14.87M
-9.05%-59.5M
15.91%-13.98M
-18.32%-13.95M
---13.19M
---18.37M
-23.49%-54.56M
---16.63M
---11.79M
Investing cash flow
Cash flow from continuing investing activities
-458.97%-218K
-193K
81.69%-165K
31.78%-73K
86.75%-53K
-39K
0
-379.26%-901K
-107K
-400K
Net PPE purchase and sale
-446.15%-213K
---185K
82.89%-115K
-192.00%-73K
99.16%-3K
---39K
--0
-257.45%-672K
---25K
---356K
Net intangibles purchase and sale
---5K
---8K
78.17%-50K
--0
-13.64%-50K
--0
--0
---229K
---82K
---44K
Cash from discontinued investing activities
Investing cash flow
-458.97%-218K
---193K
81.69%-165K
31.78%-73K
86.75%-53K
---39K
--0
-379.26%-901K
---107K
---400K
Financing cash flow
Cash flow from continuing financing activities
409.57%291K
90,563.27%88.65M
54,815.87%103.79M
123,644.44%100.07M
11,277.14%3.91M
-94K
-98K
-99.87%189K
-81K
-35K
Net issuance payments of debt
28.16%-74K
0.91%-109K
2,293.25%3.58M
2.78%-105K
10,913.89%3.89M
---103K
---110K
---163K
---108K
---36K
Net common stock issuance
---54K
--88.75M
--100.25M
----
----
--0
--0
--0
----
----
Net preferred stock issuance
----
----
--0
--0
----
----
----
-99.99%20K
---1K
--1K
Proceeds from stock option exercised by employees
4,555.56%419K
-16.67%10K
-84.64%51K
--0
--30K
--9K
--12K
95.29%332K
--28K
--0
Net other financing activities
----
----
---86K
---75K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
409.57%291K
90,563.27%88.65M
54,815.87%103.79M
123,644.44%100.07M
11,277.14%3.91M
---94K
---98K
-99.87%189K
---81K
---35K
Net cash flow
Beginning cash position
----
54.76%124.72M
-40.68%80.59M
-60.27%38.7M
----
----
--80.59M
362.53%135.86M
--97.4M
--109.63M
Current changes in cash
----
498.41%73.59M
179.84%44.13M
592.23%82.76M
----
----
---18.47M
-151.90%-55.27M
---16.81M
---12.22M
End cash Position
----
219.26%198.31M
54.76%124.72M
54.76%124.72M
----
----
--62.12M
-40.68%80.59M
--80.59M
--97.4M
Free cash flow
-53.96%-20.37M
18.04%-15.06M
-7.57%-59.66M
16.01%-14.05M
-14.87%-14M
---13.23M
---18.37M
-25.00%-55.46M
---16.73M
---12.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -52.76%-20.15M19.09%-14.87M-9.05%-59.5M15.91%-13.98M-18.32%-13.95M-13.19M-18.37M-23.49%-54.56M-16.63M-11.79M
Net income from continuing operations -58.00%-21.24M-16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M---13.44M---18.66M-17.10%-59.28M---14.58M---17.06M
Depreciation and amortization 11.21%496K6.49%476K60.96%1.84M10.11%490K34.50%460K--446K--447K8,707.69%1.15M--445K--342K
Other non cash items ----------530K--258K------------------------
Change In working capital -93.65%-2.26M814.44%4.01M-17.25%1.48M55.36%-1.35M1.36%4.55M---1.17M---561K-70.35%1.79M---3.02M--4.49M
-Change in prepaid assets 557.98%861K-138.36%-201K152.46%990K184.30%698K-109.89%-44K---188K--524K-247.51%-1.89M---828K--445K
-Change in payables and accrued expense -297.59%-2.81M707.25%4.52M-52.56%1.91M13.18%-1.73M20.31%5.09M---706K---745K-39.67%4.03M---1.99M--4.23M
-Change in other current liabilities -14.39%-310K7.35%-315K-366.78%-1.42M-59.80%-318K-170.72%-490K---271K---340K---304K---199K---181K
-Change in other working capital ----------------------------50.54%-46K--0--0
Cash from discontinued investing activities
Operating cash flow -52.76%-20.15M19.09%-14.87M-9.05%-59.5M15.91%-13.98M-18.32%-13.95M---13.19M---18.37M-23.49%-54.56M---16.63M---11.79M
Investing cash flow
Cash flow from continuing investing activities -458.97%-218K-193K81.69%-165K31.78%-73K86.75%-53K-39K0-379.26%-901K-107K-400K
Net PPE purchase and sale -446.15%-213K---185K82.89%-115K-192.00%-73K99.16%-3K---39K--0-257.45%-672K---25K---356K
Net intangibles purchase and sale ---5K---8K78.17%-50K--0-13.64%-50K--0--0---229K---82K---44K
Cash from discontinued investing activities
Investing cash flow -458.97%-218K---193K81.69%-165K31.78%-73K86.75%-53K---39K--0-379.26%-901K---107K---400K
Financing cash flow
Cash flow from continuing financing activities 409.57%291K90,563.27%88.65M54,815.87%103.79M123,644.44%100.07M11,277.14%3.91M-94K-98K-99.87%189K-81K-35K
Net issuance payments of debt 28.16%-74K0.91%-109K2,293.25%3.58M2.78%-105K10,913.89%3.89M---103K---110K---163K---108K---36K
Net common stock issuance ---54K--88.75M--100.25M----------0--0--0--------
Net preferred stock issuance ----------0--0-------------99.99%20K---1K--1K
Proceeds from stock option exercised by employees 4,555.56%419K-16.67%10K-84.64%51K--0--30K--9K--12K95.29%332K--28K--0
Net other financing activities -----------86K---75K------------------------
Cash from discontinued financing activities
Financing cash flow 409.57%291K90,563.27%88.65M54,815.87%103.79M123,644.44%100.07M11,277.14%3.91M---94K---98K-99.87%189K---81K---35K
Net cash flow
Beginning cash position ----54.76%124.72M-40.68%80.59M-60.27%38.7M----------80.59M362.53%135.86M--97.4M--109.63M
Current changes in cash ----498.41%73.59M179.84%44.13M592.23%82.76M-----------18.47M-151.90%-55.27M---16.81M---12.22M
End cash Position ----219.26%198.31M54.76%124.72M54.76%124.72M----------62.12M-40.68%80.59M--80.59M--97.4M
Free cash flow -53.96%-20.37M18.04%-15.06M-7.57%-59.66M16.01%-14.05M-14.87%-14M---13.23M---18.37M-25.00%-55.46M---16.73M---12.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg